The Motley FoolTue, 30 Jun 2026 11:45:03 GMTRecursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?SMMT-1.64%
Seeking AlphaMon, 22 Jun 2026 13:05:03 GMTSummit Therapeutics: High-Volatility, Catalyst-Driven Binary BetSMMT-1.64%
Seeking AlphaMon, 08 Jun 2026 19:08:30 GMTSummit Therapeutics Inc. (SMMT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSMMT-1.64%
Zacks Investment ResearchThu, 04 Jun 2026 17:01:10 GMTAll You Need to Know About Summit Therapeutics (SMMT) Rating Upgrade to BuySMMT-1.64%
Seeking AlphaMon, 01 Jun 2026 17:54:03 GMTSummit Therapeutics Inc. (SMMT) Discusses Plenary Session Updates and Recent Clinical Data Following Major Oncology Congress TranscriptSMMT-1.64%
BenzingaMon, 01 Jun 2026 14:56:56 GMTWhat's Going On With Summit Therapeutics Stock On Monday?SMMT-1.64%
Zacks Investment ResearchMon, 01 Jun 2026 14:56:18 GMTWall Street Analysts Think Summit Therapeutics (SMMT) Could Surge 67.1%: Read This Before Placing a BetSMMT-1.64%
Market WatchMon, 01 Jun 2026 12:06:00 GMTAn experimental lung-cancer drug could replace Keytruda one day. But investors aren't wowed.SMMT-1.64%
CNBCSun, 31 May 2026 12:00:02 GMTA hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in ChinaSMMT-1.64%
Zacks Investment ResearchFri, 22 May 2026 14:31:23 GMTHere's Why You Should Add SMMT Stock to Your Portfolio NowSMMT-1.64%
Zacks Investment ResearchMon, 04 May 2026 18:15:18 GMTSMMT Q1 Loss Narrower Than Expected, Stock Down on Ivonescimab SetbackSMMT-1.64%
24/7 Wall StreetMon, 04 May 2026 15:07:33 GMTBuy These 3 Clinical-Stage Biotechs Under $30 With Solid Cash RunwaysSMMT-1.64%
BenzingaFri, 01 May 2026 15:12:01 GMTSummit Therapeutics Stock Dips After Q1 Financial ReportSMMT-1.64%
Zacks Investment ResearchThu, 16 Apr 2026 16:30:46 GMTSMMT Stock Up 24% in Three Months: Here's What You Need to KnowSMMT-1.64%
